Novartis – science based innovation for better patient outcomes

Primary tabs

Novartis – science based innovation for better patient outcomes

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Content from this campaign

Novartis Forms Alliance to Develop Medicines for Treating Infectious Diarrheal Disease
Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis drug candidate KDU731 for the treatment of cryptosporidiosis Cryptosporidiosis is the second leading cause of infectious diarrhea in children Private companies, governments, non-governmental organizations, academia, and other stakeholders need to...
Feb 14, 2018 3:15 AM ET
Novartis Foundation Aims to Improve Cardiovascular Health as the Better Hearts Better Cities Initiative Gains Momentum Announcing New Partners and Confirming São Paulo as the Third City
Two new partners join the multisector initiative: the CDC Foundation and the American Heart Association. São Paulo, Brazil has been selected as a third city for Better Hearts Better Cities, following Ulaanbaatar, Mongolia and Dakar, Senegal. Better Hearts Better Cities has made significant progress in mobilizing a broad network of partners and...
Dec 14, 2017 7:00 AM ET
World Heart Day 2017 – a Global Vision for Healthy Hearts
Cardiovascular diseases, including hypertension, account for nearly half of the world’s deaths from non-communicable diseases (NCDs).[1] With almost 75% of NCD deaths occurring in LMICs,[2] the...
Sep 29, 2017 3:00 AM ET
Novartis Ranks Fourth in Fortune’s “Change the World” List and Moves up in Dow Jones Sustainability Index
September 11, 2017 /3BL Media/ - Novartis has again been recognized for its commitment to doing well by doing good in key global rankings. Fortune’s “Change the World” list, published online on Thursday, September 7, placed Novartis in fourth place out of 50 companies listed. The list, now in its third year, recognizes companies that have a positive social impact through...
Sep 11, 2017 8:35 AM ET
Novartis Joins Global Initiative to Fight the Rise of Noncommunicable Diseases
January 18, 2016 /3BL Media/ - On January 18, 2017 at the World Economic Forum in Davos, Switzerland, Novartis joins more than 20 leading biopharmaceutical companies to launch “Access Accelerated”, a global initiative to further advance access to prevention and care for noncommunicable diseases (NCDs) in low and lower-middle income countries (LICs and LMICs). Chronic conditions such as...
Jan 18, 2017 8:00 AM ET

Pages